Tong Jiao

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Targeting Arginase 1 but Not Arginase 2 Protects from Myocardial Ischemia-Reperfusion Injury via Nitric Oxide Signaling by Red Blood Cells in Type 2 Diabetes.

Targeting Arginase 1 but Not Arginase 2 Protects from Myocardial Ischemia-Reperfusion Injury via Nitric Oxide Signaling by Red Blood Cells in Type 2 Diabetes.

Journal: Antioxidants (Basel, Switzerland)
Published: November 21, 2025

microRNA-210 in red blood cells differentially regulates vascular endothelial function between type 1 and type 2 diabetes.

microRNA-210 in red blood cells differentially regulates vascular endothelial function between type 1 and type 2 diabetes.

Journal: Physiological reports
Published: November 21, 2025

Long Duration of Type 2 Diabetes Drives Erythrocyte-Induced Vascular Endothelial Dysfunction: A Link to miRNA-210-3p.

Long Duration of Type 2 Diabetes Drives Erythrocyte-Induced Vascular Endothelial Dysfunction: A Link to miRNA-210-3p.

Journal: Diabetes
Published: May 14, 2025

T cell-derived adenosine regulates fibroblast IL-6 formation via A2B receptors in the infarcted heart.

T cell-derived adenosine regulates fibroblast IL-6 formation via A2B receptors in the infarcted heart.

Journal: Purinergic signalling
Published: February 23, 2025

Red blood cells from patients with ST-elevation myocardial infarction and elevated C-reactive protein levels induce endothelial dysfunction.

Red blood cells from patients with ST-elevation myocardial infarction and elevated C-reactive protein levels induce endothelial dysfunction.

Journal: American journal of physiology. Heart and circulatory physiology
Published: October 11, 2024

Erythrocyte-derived extracellular vesicles induce endothelial dysfunction through arginase-1 and oxidative stress in type 2 diabetes.

Erythrocyte-derived extracellular vesicles induce endothelial dysfunction through arginase-1 and oxidative stress in type 2 diabetes.

Journal: The Journal of clinical investigation
Published: March 08, 2024

Vascular disease and risk of fall-related injuries in Parkinson's disease: A nationwide cohort study in Sweden.

Vascular disease and risk of fall-related injuries in Parkinson's disease: A nationwide cohort study in Sweden.

Journal: Parkinsonism & related disorders
Published: February 16, 2024

miR-210 as a therapeutic target in diabetes-associated endothelial dysfunction.

miR-210 as a therapeutic target in diabetes-associated endothelial dysfunction.

Journal: British journal of pharmacology
Published: February 06, 2024

Hypoxic erythrocytes mediate cardioprotection through activation of soluble guanylate cyclase and release of cyclic GMP.

Hypoxic erythrocytes mediate cardioprotection through activation of soluble guanylate cyclase and release of cyclic GMP.

Journal: The Journal of clinical investigation
Published: December 01, 2022

The red blood cell as a mediator of endothelial dysfunction in patients with familial hypercholesterolemia and dyslipidemia.

The red blood cell as a mediator of endothelial dysfunction in patients with familial hypercholesterolemia and dyslipidemia.

Journal: Journal of internal medicine
Published: November 03, 2022

Stimulation of Erythrocyte Soluble Guanylyl Cyclase Induces cGMP Export and Cardioprotection in Type 2 Diabetes.

Stimulation of Erythrocyte Soluble Guanylyl Cyclase Induces cGMP Export and Cardioprotection in Type 2 Diabetes.

Journal: JACC. Basic to translational science
Published: July 22, 2022

Mendelian randomization study on the causal effects of tumor necrosis factor inhibition on coronary artery disease and ischemic stroke among the general population.

Mendelian randomization study on the causal effects of tumor necrosis factor inhibition on coronary artery disease and ischemic stroke among the general population.

Journal: EBioMedicine
Published: November 15, 2021
Showing 1-12 of 21

Last Updated: 09/26/2026